Healthy Volunteers (HV)
13
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (13)
Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants
Phase I Study of HXN6005 in Adult Healthy Participants
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer
A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants
Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease
Effects of a Sleep Education Program on the Health Status of Healthcare Workers Working 12-hour Alternating Day-night Shifts
Assessment of Glycemic Index for Dried Saskatoon Berries and Powder in Healthy Subjects
Compare the PK, Safety, and Immunogenicity of Process-Changed CMAB007 and Xolair in Healthy Adult Male Subjects
WBV Reflex Latency and Mechanical Load
Examining the Effects of Reformer Pilates Exercises on Physical Fitness and Cognitive Functions in Healthy Individuals
Effects of Integrative Neuromuscular Traning on Physical Fitness and Dribbling Performance Among High School Male Football Players in Shandong, China
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
Assessment of [18F]MNI-1054 as a Marker for LSD1